Moreover, from a clinical perspective, neutrophilic inflammation in asthmatic patients has been observed regardless of steroid therapy as well as in steroid-naïve patients [36,37]; cytokines frequently involved in T2-low asthma, such as IL-17A and IL-22, are often resistant to steroid action [8]. This evidence concerns the gene IL22 and asthma.